ConductScience.org, home

Paper39695697

Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.

Hose D and 25 others. J Hematol Oncol, 2024. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma. Papers, record 39695697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39695697

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.
PubMed
Journal
J Hematol Oncol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.5, provisional
iCite
Revised in PubMed
2025-05-15
PubMed

Authors26

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hose DDirk
2Ray SSeemun
3Rößler SSina
4Thormann UUlrich
5Schnettler RReinhard
6de Veirman KKim
7El Khassawna TThaqif
8Heiss CChristian
9Hild AAnne
10Zahner DDaniel
11Alagboso FFrancisca
12Henss AAnja
13Beck SSusanne
14Emde-Rajaratnam MMartina
15Burhenne JJürgen
16Bamberger JJuliane
17Menu EEline
18de Bruyne EElke
19Gelinsky MMichael
20Kampschulte MMarian

Source PubMed

See all 26 authorsDownload CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Multiple MyelomaMajor topic
BortezomibMajor topic
Silicon DioxideMajor topic
CollagenMajor topic
Neoplasm, ResidualMajor topic
Animals
Rats
Mice
Humans
Osteolysis
Antineoplastic Agents
Gels
Male
Cell Line, Tumor

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
SFB/TRR79Deutsche ForschungsgemeinschaftPubMed

Source PubMed

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in39856743Correction: Bortezomib-releasing silica-collagen xerogels for local treatment of osteolytic bone- and minimal residual disease in multiple myeloma.https://conductscience.org/library/papers/39856743

Source PubMed

Download CSV of comments and corrections

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1368243Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice.J Immunol1979https://conductscience.org/library/papers/368243PubMed
225477008Cellular uptake kinetics of bortezomib in relation to efficacy in myeloma cells and the influence of drug transporters.Cancer Chemother Pharmacol2015https://conductscience.org/library/papers/25477008PubMed
317910634Stimulation of new bone formation by the proteasome inhibitor, bortezomib: implications for myeloma bone disease.Br J Haematol2007https://conductscience.org/library/papers/17910634PubMed
427497232Nanocrystallinity effects on osteoblast and osteoclast response to silicon substituted hydroxyapatite.J Colloid Interface Sci2016https://conductscience.org/library/papers/27497232PubMed
539119424Chemotherapy Release From Bortezomib-Impregnated Polymethylmethacrylate-Coated Intramedullary Nails: A Novel In Vitro Study for a Local Chemotherapy Delivery Device.Cureus2024https://conductscience.org/library/papers/39119424PubMed
615461798Bioconductor: open software development for computational biology and bioinformatics.Genome Biol2004https://conductscience.org/library/papers/15461798PubMed
733284948A large meta-analysis establishes the role of MRD negativity in long-term survival outcomes in patients with multiple myeloma.Blood Adv2020https://conductscience.org/library/papers/33284948PubMed
820533309Guidelines for assessment of bone microstructure in rodents using micro-computed tomography.J Bone Miner Res2010https://conductscience.org/library/papers/20533309PubMed
930606515Effects of MgO, ZnO, SrO, and SiO2 in tricalcium phosphate scaffolds on in vitro gene expression and in vivo osteogenesis.Mater Sci Eng C Mater Biol Appl2019https://conductscience.org/library/papers/30606515PubMed
1030079070CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma-Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance.Front Immunol2018https://conductscience.org/library/papers/30079070PubMed
1119281987Quantitative measures of femoral fracture repair in rats derived by micro-computed tomography.J Biomech2009https://conductscience.org/library/papers/19281987PubMed
1217371942The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients.Blood2007https://conductscience.org/library/papers/17371942PubMed
1325293776Curing myeloma at last: defining criteria and providing the evidence.Blood2014https://conductscience.org/library/papers/25293776PubMed
149275021Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse.Br J Cancer1997https://conductscience.org/library/papers/9275021PubMed
1519196662Bortezomib induces osteoblast differentiation via Wnt-independent activation of beta-catenin/TCF signaling.Blood2009https://conductscience.org/library/papers/19196662PubMed
1625680544Bioactive silica nanoparticles reverse age-associated bone loss in mice.Nanomedicine2015https://conductscience.org/library/papers/25680544PubMed
1731242924Prospective target assessment and multimodal prediction of survival for personalized and risk-adapted treatment strategies in multiple myeloma in the GMMG-MM5 multicenter trial.J Hematol Oncol2019https://conductscience.org/library/papers/31242924PubMed
1812528874Review of 1027 patients with newly diagnosed multiple myeloma.Mayo Clin Proc2003https://conductscience.org/library/papers/12528874PubMed
1928686535
Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study.
J Clin Oncol2017https://conductscience.org/library/papers/28686535PubMed
2019345651Bioactive silica-collagen composite xerogels modified by calcium phosphate phases with adjustable mechanical properties for bone replacement.Acta Biomater2009https://conductscience.org/library/papers/19345651PubMed

See all 54 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
41471085Plasma Cell Myeloma: Biochemical Insights into Diagnosis, Treatment, and Smart Nanocarrier-Based Therapeutic Development.Pharmaceutics2025https://conductscience.org/library/papers/41471085PubMed
41188965Human preclinical multiple myeloma in vitro models for disease modeling and therapy screening.J Biol Eng2025https://conductscience.org/library/papers/41188965PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39695697

GET https://conductscience.org/api/papers/v1/39695697/authors?page=2